Scott Gottlieb Quotes


One of the noxious features of Obamacare was its forced march into a single, federally designed package of health benefits.


Citations

Gottlieb, Scott. "The Obamacare 'Choice' Illusion." The Wall Street Journal, 2013.

Related Quotes

A single payer system for health insurance saves an enormous amount of money—15 to 20 percent of all health payments made under all health insurance. However, this quotation from a leading Republican disclosed a split in the Republican Party. Many really would like the many billions of dollars that would be saved every year by having one organization pay all health insurance bills as Medicare did, but the large insurance companies, major contributors to Republicans, of course did not want to compete for the single payer where most would lose their administrative overhead and profits from the existing inefficient system. So austerity, normally a strong Republican principle, gave way to the profits of an important Republican contributor base.


Scott Gottlieb
Scott Gottlieb
  • Born: June 11, 1972
  • Nationality: American
  • Profession: Public Servant

Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from 2017 until April 2019. He is presently a resident fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., and a contributor to the cable financial news network CNBC. Before becoming FDA commissioner, he was a clinical assistant professor at New York University School of Medicine, the FDA deputy commissioner for medical and scientific affairs, a venture partner with New Enterprise Associates, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare and Medicaid Services, and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017 prior to joining the FDA as commissioner in May 2017.